Cellestis Limited (CST.AX) Announce Regulatory Approval In Korea For TB Diagnosis  
12/17/2007 11:30:02 AM

Melbourne, Dec 17, 2007 (ABN Newswire) - Cellestis Limited (ASX: CST) is pleased to announce it has been advised by the Korean Food and Drug Administration (KFDA) that QuantiFERON(R)-TB Gold In-Tube has received regulatory approval in the Republic of Korea (South Korea); allowing sale of the test in the Republic of Korea.